Introduction: You are invited to participate in a research study conducted by the University of Montana and approved by the University of Montana Institutional Review Board. Before you decide whether or not to participate, it is important for you to understand why the research is being done and what it will involve. Please take the time to read this form carefully before you decide whether or not to participate. There will be an opportunity to request additional information if you have questions. 

Purpose of the Study: The purpose of this study is to investigate the effectiveness of behavioral cough suppression therapy (BCST) in managing refractory chronic cough (RCC) within a group telehealth setting. RCC is a cough that has lasted at least 8 weeks and has not resolved with standard medical treatment. BCST is a research-based treatment provided by specialty-trained speech-language pathologists (SLPs) for patients with RCC. Although the treatment works very well for a large proportion of patients in a standard one-on-one format, there are a limited number of SLPs available to provide this treatment and patients living in rural areas do not typically have access to an SLP trained in BCST. If BCST can effectively be delivered in a group telehealth model, it would significantly improve accessibility to the treatment.

Please answer the following questions to determine if you qualify to participate in this study.